Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: AMRI | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: AMRI

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AMRI

2Q Revenues: $45.6 million (-12%)

2Q Loss: $353,000* (earnings were $7.3 million in 2Q2005)

YTD Revenues: $88.9 million (-12%)

YTD Earnings: $1.5 million (earnings were $12.9 million YTD2005)

Comments: Revenue for Discovery Services in the second quarter was $9.4 million, up 48%. Revenue from Development and Small Scale Manufacturing in the quarter was $8.2 million, up 17%. Large Scale Manufacturing revenues were $20.8 million, down 8%. Royalties from Allegra were down 55% to $7.2 million, due to generic competition.

*Earnings for the quarter reflect an impairment charge of $2.2 million related to Mount Prospect Research Center.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters